Market revenue in 2022 | USD 453.0 million |
Market revenue in 2030 | USD 1,134.5 million |
Growth rate | 12.2% (CAGR from 2022 to 2030) |
Largest segment | Polyvinyl chloride (pvc) |
Fastest growing segment | Polyvinyl Chloride (PVC) |
Historical data | 2019 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Polyethylene (PE), Polypropylene (PP), Acrylonitrile Butadiene Styrene (ABS), Polyethylene Terephthalate (PET), Polyvinyl Chloride (PVC), Polytetrafluoroethylene (PTFE), Polycarbonate (PC), Other |
Key market players worldwide | Basf SE, LyondellBasell Industries NV Class A, SABIC, LG Chem, Toray Industries Inc, Solvay SA, Dow Inc, DuPont de Nemours Inc, Compagnie de Saint-Gobain SA, Tekni-Plex, Chevron Corp, Exxon Mobil Corp, Covestro AG, Teijin Ltd, Mitsui Chemicals Inc, Formosa Plastics Group, CHIMEI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharma plastics market will help companies and investors design strategic landscapes.
Polyvinyl chloride (pvc) was the largest segment with a revenue share of 21.26% in 2024. Horizon Databook has segmented the China biopharma plastics market based on polyethylene (pe), polypropylene (pp), acrylonitrile butadiene styrene (abs), polyethylene terephthalate (pet), polyvinyl chloride (pvc), polytetrafluoroethylene (ptfe), polycarbonate (pc), other covering the revenue growth of each sub-segment from 2019 to 2030.
The biopharma plastics market in China is projected to witness substantial growth over the forecast period. The growth can be attributed to high healthcare costs, increasing private and public expenditure on biopharma industry, and the growing burden of diseases.
Furthermore, the increasing geriatric population is expected to be a major contributor to the healthcare industry, which is expected to positively impact the biopharma plastics market over the forecast period.
Amid the rising cases of the COVID-19 in China, the demand for medical equipment, including medical components, surgical tools, face masks, gloves & aprons, ventilators, and others which are being exported to various countries such as the U.S., the UK, Spain, Italy, and India, can positively impact the biopharma plastics market.
Horizon Databook provides a detailed overview of country-level data and insights on the China biopharma plastics market , including forecasts for subscribers. This country databook contains high-level insights into China biopharma plastics market from 2019 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account